As we enter March, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and categories on BPIQ.com compared to XBI.
Table 1. BPIQ company weekly moves and YTD moves
Highlights for the week of 3/7 - 3/11
Biggest positive move
$KALA +132% Kala Pharmaceuticals Announces EYSUVIS® Now Covered on UnitedHealthcare Commercial and Cigna Medicare.
Biggest negative move
$BCEL -40.6% Atreca Participated in Cowen 42nd Annual Healthcare Conference
Additional big moves
$TXMD +43.1% TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx.
$CLSD +42.6% Clearside Biomedical Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
$TLSA +30.4% Tiziana Announces Positive Clinical Data from A Secondary Progressive Multiple Sclerosis Patient Treated for Six Months with Intranasally Administered Foralumab, A Fully Human Anti-CD3 Monoclonal Antibody
$CCCC +15.3% C4 Therapeutics Announces FDA Orphan Drug Designation for CFT8634 for the Treatment of Soft Tissue Sarcoma.
$CARA +11.0% Cara Therapeutics Announces Oral KORSUVA™ (difelikefalin) Data Selected for Late-Breaking Presentation at 2022 American Academy of Dermatology Annual Meeting
$ORPH -45.8% Commencement of in-court restructuring of Orphazyme A/S
$NEXI -27.5% NexImmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
Highlights for next week
Companies with commercial assets reporting Q4 '21 results next week:
$ETON
$CPRX
$ATNX
$PRTK
$AVEO
$JAGX
Additional events:
$CARA Phase 3 updates at investor day
$ATXI OND response to FDRR
$BBIO Phase 2 data presentation
Watch over the next few weeks for quarterly company reports including commercial sales
See our Big Movers post to learn about the upcoming March Big Movers/Movers to Watch (includes several PDUFAs or the month)
Comments